will tirzepatide no longer be available is in SHORTAGE. What You Need to Know tirzepatide march 2025 Are You

Pediatric Use The FDA approved liraglutide (Saxenda) for pediatric obesity in patients aged 12 and older in December 2020, and semaglutide (Wegovy) received approval for adolescents aged 12 and older in December 2022

Even as thousands of people have been laid off from HHS amid widespread government staffing cuts, the administration has signaled it wants to boost CMMI, which is running the experiment on funding GLP-1 medications

A typical maintenance meal might include 46 ounces of protein, 2 cups of non-starchy vegetables, and a palm-sized portion of whole grains

Initially developed for Type 2 Diabetes (T2D), GLP-1 drugs are now widely used in obesity/weight loss management, with emerging applications in cardiovascular and neurodegenerative diseases